Filing Flows › Boston Scientific (BSX) › Endoscopy revenue
Boston Scientific (BSX) Endoscopy revenue by quarter
Boston Scientific's Endoscopy revenue was $741M in Q3 2026 (third quarter 2026), -7% from Q2 2026. Over the last 6 quarters it ranged from $673M (Q1 2025) to $793M (Q2 2026).
| Quarter | Endoscopy revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $741M | -7% | -0.8% |
| Q2 2026 | $793M | +8% | +8% |
| Q1 2026 | $736M | -1% | +9% |
| Q3 2025 | $747M | +1% | — |
| Q2 2025 | $737M | +10% | — |
| Q1 2025 | $673M | — | — |
Q3 2026 at a glance
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Boston Scientific's Endoscopy revenue?
Boston Scientific's Endoscopy revenue was $741M in Q3 2026 (third quarter 2026), -7% from Q2 2026.
How has Boston Scientific's Endoscopy revenue changed?
Over the last 6 quarters it ranged from $673M (Q1 2025) to $793M (Q2 2026).